Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cardiology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cardiology Other
    Rosuvastatin Approved for US Adults With No Clinically Evident Cardiovascular Disease - (DGNews)
    Non-invasive cardiac stress testing before elective major non-cardiac surgery: population based cohort study - (BMJ)
    Valve Replacement Safe for Patients With End-Stage Renal Disease on Dialysis: Presented at STS - (DGDispatch)
    Mechanical Valves Preferable for Tricuspid Valve Replacement: Presented at STS - (DGDispatch)
    On-Pump CABG Should Be Avoided in Patients With Liver Cirrhosis: Presented at STS - (DGDispatch)

    News archive

     Recent webcasts/CME - Cardiology Other
      Cardiovascular Disease in Inflammatory Arthritis: Getting to the Heart of the Matter
      Faculty Feud: Current Concepts in the Pathogenesis and Treatment of Pulmonary Arterial Hypertension
      The Metabolic Syndrome in Transplantation: Risk of CV Events and Implications for Immunosuppression
      CSI: PAH Case Study Investigation (CSI) Diagnosis and Management of Pulmonary Arterial Hypertension--Case Review Monograph
      Incretin-Related Therapies in Diabetes: Virtual Grand Rounds Approaches to Reducing CVD Risk in a Patient With Diabetes

      Webcasts/CME archive

       Recent cases - Cardiology Other
        Unusual Right Ventricular Thrombus in a Woman with Hughes-Stovin Syndrome
        Iatrogenic Intrapericardial Diaphragmatic Hernia Diagnosed By Cardiovascular Magnetic Resonance
        Cytomegalovirus (CMV) and Acute Myocarditis in an Immunocompetent Patient
        Apical Ballooning Syndrome Secondary To Nasal Decongestant Abuse
        Thrombolytic Therapy in Pulmonary Embolism

        Cases archive
          




        my personal edition > cardiology other > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Methadone Use for Pain Control May Result in Death and Life-Threatening Changes in Breathing and Heart Beat

        BETHESDA, MD -- November 27, 2006 -- US Food and Drug Administration (FDA) has received reports of death and life-threatening side effects in patients taking methadone. These deaths and life-threatening side effects have occurred in patients newly starting methadone for pain control and in patients who have switched to methadone after being treated for pain with other strong narcotic pain relievers.

        Methadone can cause slow or shallow breathing and dangerous changes in heart beat that may not be felt by the patient.

        Prescribing methadone is complex. Methadone should only be prescribed for patients with moderate to severe pain when their pain is not improved with other non-narcotic pain relievers. Pain relief from a dose of methadone lasts about 4 to 8 hours. However methadone stays in the body much longer -- from 8 to 59 hours after it is taken. As a result, patients may feel the need for more pain relief before methadone is gone from the body. Methadone may build up in the body to a toxic level if it is taken too often, if the amount taken is too high, or if it is taken with certain other medicines or supplements.

        To prevent serious complications from methadone, health care professionals who prescribe methadone should read and carefully follow the methadone (Dolophine) prescribing information

        FDA is issuing this public health advisory to alert patients and their caregivers and health care professionals to the following important safety information:

        · Patients should take methadone exactly as prescribed. Taking more methadone than prescribed can cause breathing to slow or stop and can cause death. A patient who does not experience good pain relief with the prescribed dose of methadone, should talk to his or her doctor.

        · Patients taking methadone should not start or stop taking other medicines or dietary supplements without talking to their health care provider. Taking other medicines or dietary supplements may cause less pain relief. They may also cause a toxic buildup of methadone in the body leading to dangerous changes in breathing or heart beat that may cause death.

        · Health care professionals and patients should be aware of the signs of methadone overdose. Signs of methadone overdose include trouble breathing or shallow breathing; extreme tiredness or sleepiness; blurred vision; inability to think, talk or walk normally; and feeling faint, dizzy or confused. If these signs occur, patients should get medical attention right away.

        FDA recently approved new prescribing information for methadone products approved for pain control. The information in the new prescribing information is based on a review of the scientific literature completed by FDA. A Medication Guide for patients is planned.


        SOURCE: Food and Drug Administration



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send